Chest Medicine | Page 76 of 170 | Links Medicus Content Curation & Alerts in Medicine

The Utility of Chest CT imaging in suspected or diagnosed COVID-19 Patients – a review of literature

27 Apr, 2021 | 08:30h | UTC

The Utility of Chest CT imaging in suspected or diagnosed COVID-19 Patients – a review of literature – CHEST Journal

Clinical Manifestation, Evaluation, and Rehabilitative Strategy of Dysphagia Associated With COVID-19

27 Apr, 2021 | 08:29h | UTC

Clinical Manifestation, Evaluation, and Rehabilitative Strategy of Dysphagia Associated With COVID-19 – American Journal of Physical Medicine & Rehabilitation

Multicenter cohort study shows survival among ECMO-assisted patients is strongly associated with center experience

25 Apr, 2021 | 22:05h | UTC

Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study – The Lancet Respiratory Medicine

Invited commentary: COVID-19 and ECMO: a call for close cooperation and more investigation – The Lancet Respiratory Medicine

Commentary on Twitter

#ECMO network & outcomes during #COVID19 #pandemic in Paris:
➡️17 #ICUs
➡️6 mobile teams
➡️302 pts
➡️46% 90d survival, strongly associated with center experience.
Early #ECLS in high VV volume center advocated: centralize & regulate indications!@TheLancet https://t.co/PqAYWY82Hs pic.twitter.com/ironyGdyFa

— M Velia Antonini (@FOAMecmo) April 21, 2021

U.S. lifts pause on use of J&J’s Covid-19 vaccine

25 Apr, 2021 | 21:57h | UTC

U.S. lifts pause on use of J&J’s Covid-19 vaccine – STAT

Long Covid: Largest post-acute COVID-19 study to date examined the health outcomes in more than 73,000 people who’d had COVID-19 and were not hospitalized

23 Apr, 2021 | 08:48h | UTC

High-dimensional characterization of post-acute sequalae of COVID-19 – Nature

Commentary: Among COVID-19 survivors, an increased risk of death, serious illness – Washington University School of Medicine

Commentary on Twitter (thread – click for more)

Happy to share the latest paper from our team in @nature

A comprehensive characterization of post acute sequelae of COVID-19#longcovid #PASC https://t.co/AGLnYCamWe @VAResearch @vahsrd @WUSTL @WUSTLpubhealth @WUSTLmed @WUSTLnews @VREFSTL @Biostayan @BCBowe

— Ziyad Al-Aly, MD (@zalaly) April 22, 2021

NIH Updates COVID-19 Treatment Guidelines – adds recommendations on colchicine, fluvoxamine, and monoclonal antibodies

23 Apr, 2021 | 08:46h | UTC

NIH Coronavirus Disease 2019 (COVID-19)
Treatment Guidelines – National Institutes of Health

RCT: COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir

23 Apr, 2021 | 08:42h | UTC

COVID outpatients don’t benefit from hydroxychloroquine, lopinavir-ritonavir – CIDRAP

Original study: Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial – JAMA Network Open

Commentary on Twitter (thread – Click for more)

1/ No benefit from Hydroxychloroquine or Lopinavir-Ritonavir on Hospitalization/Viral clearance for COVID-19 https://t.co/yhXxv26418 via @JAMANetworkOpen part of @JAMANetwork

— Priya Sampathkumar (@PSampathkumarMD) April 22, 2021

Case series of 18 male adults aged 50 years or younger with acute ischemic stroke during the convalescent phase of asymptomatic Covid-19

23 Apr, 2021 | 08:39h | UTC

Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men – JAMA Network Open

Commentary: ‘The next wave of complications’: Asymptomatic COVID-19 patients face a prolonged stroke risk – Cardiovascular Business

Commentary on Twitter

A 💥🆕 case series highlights that adults 50 years or younger with asymptomatic COVID-19 infection diagnosed by positive SARS-CoV-2 serological test result may present with ischemic stroke during the convalescent phase of the infection
https://t.co/BVlo7Z1hgn @JAMANetworkOpen

— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) April 22, 2021

Covid-19: More data on the increased risks to pregnant women and their newborn infants

23 Apr, 2021 | 08:44h | UTC

Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study – JAMA Pediatrics

Editorial: COVID-19 in Pregnant Women and Their Newborn Infants

Commentaries: Pregnant women with COVID-19 face high mortality rate – University of Washington School of Medicine AND Covid-19 raises risks for expectant mothers and babies, study says – CNN

Commentary on Twitter

18 country study in >2000 pregnant women with and without #COVID19 shows higher complication and death rates in symptomatic, but not asymptomatic, women with COVID-19. Their babies were at greater risk of neonatal complications, mainly due to preterm birth https://t.co/mRl8OOIMsz

— JAMA Pediatrics (@JAMAPediatrics) April 22, 2021

RCT: Single-Dose Johnson & Johnson Vaccine has 85% efficacy against severe/critical Covid-19 and maintains efficacy against variant B.1.351

22 Apr, 2021 | 08:50h | UTC

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 – New England Journal of Medicine

Covid-19: What do we know about airborne transmission of SARS-CoV-2?

23 Apr, 2021 | 08:33h | UTC

Covid-19: What do we know about airborne transmission of SARS-CoV-2? – The BMJ

Guideline: Diagnosis and Evaluation of Hypersensitivity Pneumonitis

22 Apr, 2021 | 08:21h | UTC

Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report – CHEST

Systematic review: Venoarterial Extracorporeal Membrane Oxygenation in Massive Pulmonary Embolism-Related Cardiac Arrest

22 Apr, 2021 | 08:18h | UTC

Venoarterial Extracorporeal Membrane Oxygenation in Massive Pulmonary Embolism-Related Cardiac Arrest: A Systematic Review – Critical Care Medicine

Summary: VA ECMO for Massive PE + Cardiac Arrest – Journal Feed

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

22 Apr, 2021 | 08:47h | UTC

Vaccine Breakthrough Infections with SARS-CoV-2 Variants – New England Journal of Medicine

Commentary on Twitter

Mild #COVID19 symptoms developed in two fully vaccinated persons. Serum tests showed high titers of antibodies capable of neutralizing the wild-type strain of #SARSCoV2 first identified in Wuhan, China, but sequencing of the virus isolates revealed novel variants.

— NEJM (@NEJM) April 21, 2021

Study shows low incidence of post-acute COVID-19 symptoms (“Long Covid”) in children after mild disease

22 Apr, 2021 | 08:40h | UTC

Post-acute COVID-19 outcomes in children with mild and asymptomatic disease – The Lancet Child & Adolescent Health

Commentaries on Twitter

Early data from @RCHMelbourne show that, at 3-6 month follow-up, all 151 children with mild and asymptomatic #COVID19 had returned to their baseline health status and post-acute COVID-19 symptoms had resolved.

Letter from @Shidan_Tosif & colleagues: https://t.co/XXa0EPIgPY

— The Lancet Child & Adolescent Health (@LancetChildAdol) April 20, 2021

Given such little available data, this study from Australia on post-acute COVID-19 symptoms in children is very important

Findings are extremely reassuring

Post-acute symptoms were rare, and mild (cough 4%, fatigue 2%, cough and fatigue 1%)

Great news!https://t.co/TEJyES3Crx

— Alasdair Munro (@apsmunro) April 21, 2021

Great to see research looking at whether long Covid is a problem in children.

From this Melbourne cohort, enduring cough and fatigue are uncommon.

It hasn’t been clear to me whether borders will reopen before children are vaccinated so this is VIP https://t.co/iLXqwXJmOt

— Jin Russell (@DrJinRussell) April 21, 2021

Truly encouraging data on post-acute #COVID19 in children. Single-center in Australia. n=151.
8% post-acute symptoms – all symptomatic COVID-19.
Mild symptoms: cough 4%, fatigue 2%, both 1%. Duration: cough 3-8w; post-viral fatigue 6-8w. All solved in follow-up time 3-6 months. https://t.co/vKrEFZlw3C

— Pablo Guisado Vasco (@PabloGVasco) April 21, 2021